Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy

PURPOSE: Antiangiogenic drugs usually have short-acting efficacy and poor treatment compliance. The purpose of this study was to determine whether mesoporous silica nanoparticles (MSNs) could be utilized as a nanodrug delivery system for improving antiangiogenic therapy. MATERIALS AND METHODS: MSN-e...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Jian-Guo, Jiang, Qin, Zhang, Xiao-Pei, Shan, Kun, Liu, Bai-Hui, Zhao, Chen, Yan, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396882/
https://www.ncbi.nlm.nih.gov/pubmed/30880960
http://dx.doi.org/10.2147/IJN.S195504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396882/
https://www.ncbi.nlm.nih.gov/pubmed/30880960
http://dx.doi.org/10.2147/IJN.S195504

Ejemplares similares